Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMorgan Sindall Group Regulatory News (MGNS)

Share Price Information for Morgan Sindall Group (MGNS)

Share Price is delayed by 15 minutes
Get Live Data
4,788.00    -94.00 (-1.93%)
Bid:
4,780.00
Ask:
4,782.00
Spread: 2.00 (0.042%)
Market Cap: £2.23b
MGNS Live PriceLast checked at - London Stock Exchange

Intraday Morgan Sindall Group Share Chart

Holding(s) in Company

28 Mar 2013 17:22

RNS Number : 2137B
Morgan Sindall Group PLC
28 March 2013
Β 

ο»Ώ

Β 

Β 

TR-1: Notifications of Major Interests in Shares

Β 

1: Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

Morgan Sindall Group plc

Β 

2: Reason for notification (yes/no)

An acquisition or disposal of voting rights

yes

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

no

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

no

An event changing the breakdown of voting rights

no

Other (please specify):

Β 

no

Β 

3. Full name of person(s) subject to the notification

obligation:

Standard Life Investments Ltd

4. Full name of shareholder(s) (if different from 3.):

Vidacos Nominees

5. Date of the transaction (and date on which the threshold

is crossed or reached):

21 March 2013

6. Date on which issuer notified:

22 March 2013

7. Threshold(s) that is/are crossed or reached:

7%

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

8: Notified Details

A: Voting rights attached to shares

Class/type of share If possible use ISIN code

GB0008085614

Β 

Situation previous to the triggering transaction

Number of shares

Number of voting rights

3,127,981

3,127,981

Β 

Resulting situation after the triggering transaction

Number of shares

Number of voting rights

Percentage ofvoting rights

Direct

Indirect

Direct

Indirect

2,946,827

1,694,525

1,252,302

3.920%

2.897%

Β 

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument

Expiration date

Exercise/ conversion period/date

No. of voting rights that may be acquired(if the instrument exercised/converted)

Percentage of voting rights

Β 

Β 

Β 

Β 

Β 

Β 

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments

Resulting situation after the triggering transaction

Β 

Type of financialinstrument

Exerciseprice

Expirationdate

Exercise/Conversionperiod

Number of votingrights instrumentrefers to

% of voting rights

Β 

Β 

Β 

Β 

Β 

Β 

Nominal

Delta

Β 

Β 

Β 

Total (A+B+C)

Number of voting rights

Percentage of voting rights

2,946,827

6.817%

Β 

Β 

Β 

Β 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable:

Β 

Proxy Voting:

Β 

10. Name of the proxy holder:

Β 

11. Number of voting rights proxy holder will cease to hold:

Β 

12. Date on which proxy holder will cease to hold voting rights:

Β 

Β 

13. Additional information:

Β 

14. Contact name:

Β 

Mary Nettleship, Company Secretary

15. Contact telephone number:

Β 

020 7307 9200

Β 

Β 

Annex to Notification of Major Interests in Shares

A: Identity of the person or legal entity subject to the notification obligation

Full name (including legal form for legal entities)

Standard Life Investments Ltd

Contact address (registered office for legal entities)

Phone number & email

(0131) 245 6565

investments_mo@standardlife.com

Other useful information (at least legal representative for legal persons)

Β 

B: Identity of the notifier, if applicable

Full name

investments_mo@standardlife.com

Standard Life Investments Ltd

Contact address

Phone number & email

(0131) 245 6565

Investments_mo@standardlife.com

Other useful information (e.g. functional relationship with the person or legal entity subject to the notification obligation)

Β 

C: Additional information

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
HOLEAXDPAAFDEFF
Date   Source Headline
2nd Jul 20267:00 amRNSNotice of Half Year Results
1st Jul 20269:36 amRNSTotal Voting Rights
23rd Jun 20262:59 pmRNSDirector/PDMR Shareholding
16th Jun 20261:05 pmRNSAdmission to Trading
12th Jun 202610:25 amRNSDirector/PDMR Shareholding
4th Jun 202611:43 amRNSDirector/PDMR Shareholding
3rd Jun 202611:56 amRNSDirector/PDMR Shareholding
1st Jun 20269:27 amRNSTotal Voting Rights
27th May 20261:29 pmRNSAdmission to Trading
20th May 202611:35 amRNSIssue of Equity
7th May 202612:38 pmRNSResult of AGM
1st May 20261:33 pmRNSDirector/PDMR Shareholding
1st May 202610:57 amRNSTotal Voting Rights
20th Apr 20263:44 pmRNSHolding(s) in Company
16th Apr 20264:09 pmRNSHolding(s) in Company
16th Apr 20267:00 amRNSTrading and Outlook for 2026
14th Apr 20262:18 pmRNSAdmission to Trading
1st Apr 20269:53 amRNSTotal Voting Rights
26th Mar 20261:27 pmRNSHolding(s) in Company
24th Mar 202612:56 pmRNSAnnual Financial Report
20th Mar 202612:42 pmRNSIssue of Equity
9th Mar 20263:35 pmRNSDirector/PDMR Shareholding
9th Mar 20263:35 pmRNSDirector/PDMR Shareholding
9th Mar 20263:30 pmRNSDirector/PDMR Shareholding
9th Mar 20263:30 pmRNSDirector/PDMR Shareholding
4th Mar 20262:38 pmRNSDirector/PDMR Shareholding
4th Mar 20262:36 pmRNSDirector/PDMR Shareholding
3rd Mar 20263:33 pmRNSIssue of Equity / Admission to Trading
2nd Mar 20269:22 amRNSTotal Voting Rights
26th Feb 20269:53 amRNSDirector Declaration
25th Feb 20267:00 amRNSResults for the Full Year ended 31 December 2025
12th Feb 20267:00 amRNSTrading and Outlook for 2026
2nd Feb 20269:13 amRNSTotal Voting Rights
19th Jan 20267:00 amRNSNotice of Full Year Results
2nd Jan 202611:09 amRNSTotal Voting Rights
16th Dec 202510:16 amRNSAdditional Listing
2nd Dec 20259:12 amRNSTotal Voting Rights
25th Nov 20254:14 pmRNSHolding(s) in Company
12th Nov 20254:07 pmRNSDirector/PDMR Shareholding
3rd Nov 202510:58 amRNSTotal Voting Rights
20th Oct 202511:24 amRNSBlock listing Interim Review
20th Oct 20259:32 amRNSDirector/PDMR Shareholding
2nd Oct 20257:00 amRNSTrading Update and Outlook for 2025
1st Oct 20259:05 amRNSTotal Voting Rights
1st Sep 20258:59 amRNSTotal Voting Rights
4th Aug 20253:09 pmRNSDirector/PDMR Shareholding
1st Aug 20257:00 amRNSTotal Voting Rights
29th Jul 20257:00 amRNSResults For the Half Year (HY) Ended 30 June 2025
18th Jul 20258:40 amRNSHolding(s) in Company
1st Jul 20259:34 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.